Weight-loss jabs could become the 'new statin' for heart treatment after US regulators approve the drug

It follows the results of a major trial which found the drug, known as semaglutide, could slash the risk of a heart attack or stroke in people with obesity by around 20 per cent.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news